Potential of zinc carbide 2D monolayers as a new drug delivery system for nitrosourea (NU) anti-cancer drug

[Display omitted] •Drug delivery system (DDS) of nitrosourea (NU) anti-cancer by using of zinc carbide nanosheet (ZnC3NS) was studied.•The adsorption energy for NU drug on the ZnC3NS in the most stable complex is -1.23 eV.•Frontier molecular orbitals (FMOs), charge distribution, and electronic featu...

Full description

Saved in:
Bibliographic Details
Published in:Computational and theoretical chemistry 2022-11, Vol.1217, p.113927, Article 113927
Main Authors: Hammadi Fahad, Israa, Sadoon, Naiser, Kadhim, Mustafa M., Abbas Alhussainy, Ammar, Hachim, Safa K., Abdulwahid Abdulhussain, Munthir, Abdullaha, Sallal A.H., Mahdi Rheima, Ahmed
Format: Article
Language:English
Subjects:
adsorption energy
charge transfer
drug delivery system
natural bond orbital
zinc carbide nanosheet
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Drug delivery system (DDS) of nitrosourea (NU) anti-cancer by using of zinc carbide nanosheet (ZnC3NS) was studied.•The adsorption energy for NU drug on the ZnC3NS in the most stable complex is -1.23 eV.•Frontier molecular orbitals (FMOs), charge distribution, and electronic features were analyzed.•The results indicate that NU can be easily protonated in tumor tissues, which facilitate NU to release from ZnC3NS. One of main causes of human death is cancer, and for its treatment, a theranostics approach is necessary. In order to study drug delivery system of nitrosourea (NU) anti-cancer by using of zinc carbide nanosheet (ZnC3NS), density functional theory calculations have been performed. The topological, electronic, adsorption energies, charge transfer and drug release of NU@ZnC3NS were calculated. The obtained adsorption energy for NU@ZnC3NS is -1.23 eV. For the comparative investigation of interaction attributes of NU anticancer drug in ZnC3NS, frontier molecular orbitals, charge distribution, and electronic features were analyzed. In addition, natural bond orbital analysis indicated that charge transfer from NU to ZnC3NS has occurred. In NU@ZnC3NS complex, solvent effects are inclined to decrease binding energy of NU. The results indicate that NU can be easily protonated in tumor tissues, which facilitate NU to release from ZnC3NS. This is the first study to show that ZnC3NS is proper candidate for drug delivery of multiple NU. Therefore, we can utilize the ZnC3 nanocarrier as promising material to delivery of (NU) anti-cancer.
ISSN:2210-271X
DOI:10.1016/j.comptc.2022.113927